DZNE Maps 900 Blood Lipids, Uncovering 50-Plus New Genomic Regions
Updated
Updated · dzne.de · May 19
DZNE Maps 900 Blood Lipids, Uncovering 50-Plus New Genomic Regions
3 articles · Updated · dzne.de · May 19
More than 50 previously unknown genomic regions tied to lipid metabolism emerged from DZNE’s analysis of blood lipids, which researchers called the most detailed lipid-genetics study to date.
Over 8,000 people were included across datasets from Bonn, Brandenburg and Finland, with a genome-wide association study linking genetic variation to more than 900 different lipids.
The core dataset came from more than 6,000 adults in the long-running Rhineland Study, designed to track how people age in good health over decades.
Those genetic links could sharpen understanding of how lipid biology connects to aging and diseases including Alzheimer’s, type 2 diabetes and cardiovascular disorders, potentially aiding risk assessment, diagnostics and therapies.
Could the newly discovered genetic regions and lipid markers lead to a breakthrough in early Alzheimer’s or heart disease detection before symptoms appear?
Are lifestyle or dietary interventions able to offset genetic risks revealed by these new lipid-genetic discoveries?
How might targeting lipid metabolism genes like ABCA7 or APOE reshape future therapies for neurodegenerative and cardiovascular diseases?
Unveiling 57 Genetic Loci Shaping Blood Lipids: Breakthroughs in Lipidomics, Disease Risk, and Precision Medicine
Overview
In May 2026, the German Center for Neurodegenerative Diseases (DZNE) published a groundbreaking study that advanced our understanding of how genetics influence blood lipid levels. By analyzing blood samples from over 8,000 individuals across several cohorts, researchers mapped more than 900 different lipid species in detail. They identified 57 genomic loci linked to lipid metabolism, including 25 new discoveries, achieving an unprecedented level of precision in genetic mapping. Using cutting-edge scientific methods, Dr. Elvire Landstra and her team meticulously analyzed the genetic background of key proteins and regulatory molecules, paving the way for more personalized approaches to disease prevention and treatment.